nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results
|
Nabholtz, J.M |
|
2003 |
39 |
12 |
p. 1684-1689 6 p. |
artikel |
2 |
Are cellular polarisation and mitotic frequency prognostic factors for local recurrence in patients with ductal carcinoma in situ of the breast?
|
Idvall, I. |
|
2003 |
39 |
12 |
p. 1704-1710 7 p. |
artikel |
3 |
Assessing the evidence for organised cancer screening programmes
|
Madlensky, L |
|
2003 |
39 |
12 |
p. 1648-1653 6 p. |
artikel |
4 |
Breast cancer incidence and mortality trends in 16 European countries
|
Botha, J.L. |
|
2003 |
39 |
12 |
p. 1718-1729 12 p. |
artikel |
5 |
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening
|
Malmström, P |
|
2003 |
39 |
12 |
p. 1690-1697 8 p. |
artikel |
6 |
Calendar
|
|
|
2003 |
39 |
12 |
p. I-II nvt p. |
artikel |
7 |
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma
|
Hoar, F.J. |
|
2003 |
39 |
12 |
p. 1698-1703 6 p. |
artikel |
8 |
Does hormone replacement therapy increase the frequency of breast atypical hyperplasia in postmenopausal women? Results from the Bouches du Rhone district screening campaign
|
Gayet, A |
|
2003 |
39 |
12 |
p. 1738-1745 8 p. |
artikel |
9 |
Early breast cancer in Europe
|
Coebergh, J.W |
|
2003 |
39 |
12 |
p. 1645-1647 3 p. |
artikel |
10 |
Editorial board
|
|
|
2003 |
39 |
12 |
p. ii- 1 p. |
artikel |
11 |
Exploiting the hallmarks of cancer
|
Sledge Jr., G.W |
|
2003 |
39 |
12 |
p. 1668-1675 8 p. |
artikel |
12 |
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines
|
Cserni, G. |
|
2003 |
39 |
12 |
p. 1654-1667 14 p. |
artikel |
13 |
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening
|
Yen, M.-F. |
|
2003 |
39 |
12 |
p. 1746-1754 9 p. |
artikel |
14 |
Results from the Swiss mammography screening pilot programme
|
Bulliard, J.-L |
|
2003 |
39 |
12 |
p. 1761-1769 9 p. |
artikel |
15 |
Survival analyses from the ZEBRA study
|
Kaufmann, M. |
|
2003 |
39 |
12 |
p. 1711-1717 7 p. |
artikel |
16 |
The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas
|
Buiatti, E |
|
2003 |
39 |
12 |
p. 1776-1782 7 p. |
artikel |
17 |
The influence of a false-positive mammogram on a woman's subsequent behaviour for detecting breast cancer
|
Lampic, C. |
|
2003 |
39 |
12 |
p. 1730-1737 8 p. |
artikel |
18 |
The process of metastasisation for breast cancer
|
Engel, J. |
|
2003 |
39 |
12 |
p. 1794-1806 13 p. |
artikel |
19 |
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease
|
Duffy, S.W. |
|
2003 |
39 |
12 |
p. 1755-1760 6 p. |
artikel |
20 |
The screening debates: time for a broader approach?
|
Thornton, H. |
|
2003 |
39 |
12 |
p. 1807-1809 3 p. |
artikel |
21 |
This issue's topics
|
|
|
2003 |
39 |
12 |
p. ix-x nvt p. |
artikel |
22 |
Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark
|
Jensena, A.R. |
|
2003 |
39 |
12 |
p. 1783-1793 11 p. |
artikel |
23 |
Use of previous screening mammograms to identify features indicating cases that would have a possible gain in prognosis following earlier detection
|
Broeders, M.J.M. |
|
2003 |
39 |
12 |
p. 1770-1775 6 p. |
artikel |
24 |
Vacuum-assisted breast biopsy
|
Hoorntje, L.E. |
|
2003 |
39 |
12 |
p. 1676-1683 8 p. |
artikel |